Xueping Hu

1.3k total citations
55 papers, 784 citations indexed

About

Xueping Hu is a scholar working on Molecular Biology, Organic Chemistry and Insect Science. According to data from OpenAlex, Xueping Hu has authored 55 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 10 papers in Organic Chemistry and 9 papers in Insect Science. Recurrent topics in Xueping Hu's work include Estrogen and related hormone effects (8 papers), Insect and Pesticide Research (7 papers) and Neurobiology and Insect Physiology Research (5 papers). Xueping Hu is often cited by papers focused on Estrogen and related hormone effects (8 papers), Insect and Pesticide Research (7 papers) and Neurobiology and Insect Physiology Research (5 papers). Xueping Hu collaborates with scholars based in China, Canada and United States. Xueping Hu's co-authors include Tingjun Hou, Dongsheng Cao, Zhe Wang, Junbo Gao, Dan Li, Chao Shen, Shaoqing Du, Ercheng Wang, Xiaojun Yao and Gaoqi Weng and has published in prestigious journals such as NeuroImage, The Journal of Physical Chemistry B and Journal of Agricultural and Food Chemistry.

In The Last Decade

Xueping Hu

51 papers receiving 775 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xueping Hu China 17 413 188 135 93 71 55 784
Katrin Stierand Germany 10 677 1.6× 304 1.6× 230 1.7× 30 0.3× 97 1.4× 15 1.2k
Chetna Tyagi India 16 412 1.0× 148 0.8× 97 0.7× 34 0.4× 61 0.9× 39 687
Yanmin Zhang China 22 766 1.9× 406 2.2× 302 2.2× 51 0.5× 186 2.6× 93 1.5k
Yuno Lee South Korea 17 482 1.2× 122 0.6× 74 0.5× 19 0.2× 59 0.8× 56 717
Wibke E. Diederich Germany 22 842 2.0× 184 1.0× 247 1.8× 26 0.3× 97 1.4× 55 1.6k
Pamela Lane United States 13 778 1.9× 95 0.5× 60 0.4× 20 0.2× 77 1.1× 22 1.2k
Fabien Plisson Mexico 16 397 1.0× 124 0.7× 165 1.2× 27 0.3× 36 0.5× 26 723
Joseph A. Burlison United States 16 713 1.7× 170 0.9× 260 1.9× 23 0.2× 51 0.7× 18 1.1k
Stephani Joy Y. Macalino Philippines 12 595 1.4× 425 2.3× 153 1.1× 16 0.2× 80 1.1× 19 942

Countries citing papers authored by Xueping Hu

Since Specialization
Citations

This map shows the geographic impact of Xueping Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueping Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueping Hu more than expected).

Fields of papers citing papers by Xueping Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueping Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueping Hu. The network helps show where Xueping Hu may publish in the future.

Co-authorship network of co-authors of Xueping Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Xueping Hu. A scholar is included among the top collaborators of Xueping Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueping Hu. Xueping Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Yinjun, et al.. (2025). New mutations of acetylcholinesterase in Bactrocera dorsalis populations across southern China and impact on resistance to organophosphate. Ecotoxicology and Environmental Safety. 297. 118189–118189.
2.
Du, Shaoqing, et al.. (2025). Advances in the computational development of hepatitis B virus capsid assembly modulators. Drug Discovery Today. 30(10). 104458–104458.
3.
Sun, Lei, Ertong Li, Depeng Zhang, et al.. (2024). Identification of RdRp-NiRAN/JAK1 Dual-Target Drugs for COVID-19 Treatment. The Journal of Physical Chemistry B. 128(49). 12066–12077.
4.
Du, Shaoqing, Xueping Hu, Xinyong Liu, & Peng Zhan. (2024). Revolutionizing viral disease treatment: Phase separation and lysosome/exosome targeting as new areas and new paradigms for antiviral drug research. Drug Discovery Today. 29(3). 103888–103888. 6 indexed citations
5.
Hu, Xueping, et al.. (2024). Recent advances in the development of DprE1 inhibitors using AI/CADD approaches. Drug Discovery Today. 29(6). 103987–103987. 5 indexed citations
6.
Sun, Lei, et al.. (2024). Molecular docking with conformer-dependent charges. Physical Chemistry Chemical Physics. 26(34). 22598–22610. 5 indexed citations
7.
Chai, Xin, Xueping Hu, Xinyue Wang, et al.. (2023). Computationally guided discovery of novel non-steroidal AR-GR dual antagonists demonstrating potency against antiandrogen resistance. Acta Pharmacologica Sinica. 44(7). 1500–1518. 8 indexed citations
8.
Renouf, Elizabeth, et al.. (2023). An exploration of the relationship between wastewater viral signals and COVID-19 hospitalizations in Ottawa, Canada. Infectious Disease Modelling. 8(3). 617–631. 9 indexed citations
9.
Hu, Xueping, Jinping Pang, Changwei Chen, et al.. (2022). Discovery of novel non-steroidal selective glucocorticoid receptor modulators by structure- and IGN-based virtual screening, structural optimization, and biological evaluation. European Journal of Medicinal Chemistry. 237. 114382–114382. 20 indexed citations
10.
Deng, Xile, et al.. (2021). Phenyl imidazolidin‐2‐ones antagonize a β‐adrenergic‐like octopamine receptor in diamondback moth (Plutella xylostella). Pest Management Science. 77(7). 3224–3232. 11 indexed citations
11.
Hu, Xueping, Xin Chai, Qing Ye, et al.. (2021). Opportunities for overcoming tuberculosis: Emerging targets and their inhibitors. Drug Discovery Today. 27(1). 326–336. 16 indexed citations
12.
Hu, Xueping, Jinping Pang, Jintu Zhang, et al.. (2021). Discovery of Novel GR Ligands toward Druggable GR Antagonist Conformations Identified by MD Simulations and Markov State Model Analysis. Advanced Science. 9(3). e2102435–e2102435. 35 indexed citations
13.
Hu, Xueping, Xin Chai, Md Shah Alam, et al.. (2021). Discovery of novel DprE1 inhibitors via computational bioactivity fingerprints and structure-based virtual screening. Acta Pharmacologica Sinica. 43(6). 1605–1615. 13 indexed citations
14.
Du, Shaoqing, Xueping Hu, Mengnan Li, et al.. (2021). Discovery of novel iminosydnone compounds with insecticidal activities based on the binding mode of triflumezopyrim. Bioorganic & Medicinal Chemistry Letters. 46. 128120–128120. 15 indexed citations
15.
Hu, Xueping, Xin Chai, Xuwen Wang, et al.. (2020). Advances in the computational development of androgen receptor antagonists. Drug Discovery Today. 25(8). 1453–1461. 21 indexed citations
16.
Weng, Gaoqi, Junbo Gao, Zhe Wang, et al.. (2020). Comprehensive Evaluation of Fourteen Docking Programs on Protein–Peptide Complexes. Journal of Chemical Theory and Computation. 16(6). 3959–3969. 119 indexed citations
17.
Wang, Zhe, Huiyong Sun, Chao Shen, et al.. (2020). Combined strategies in structure-based virtual screening. Physical Chemistry Chemical Physics. 22(6). 3149–3159. 85 indexed citations
18.
Huang, Yi, Lei Hu, Guoping Liu, et al.. (2012). Selective delivery of interleukine-1 receptor antagonist to inflamed joint by albumin fusion. BMC Biotechnology. 12(1). 68–68. 28 indexed citations
19.
Hu, Xueping, Stephen W. Lagakos, & Richard Lockhart. (2009). Marginal analysis of panel counts through estimating functions. Biometrika. 96(2). 445–456. 14 indexed citations
20.
Hu, Xueping, et al.. (1997). Characterization of a BMS-181174-resistant human bladder cancer cell line. British Journal of Cancer. 76(4). 461–466. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026